8-K/A

FORM 8-K AMENDMENT NO. 1

Company: Aldeyra Therapeutics, Inc.
Filed: May 19, 2017
Period of Report: May 15, 2017
Accession Number: 0001193125-17-176590

View Document ↗ View on SEC.gov ↗